Impaired H3K36 methylation defines a subset of head and neck squamous cell carcinomas

Area of Science:

• Oncology
• Epigenetics
• Genomics

Background:

• Human papillomavirus (HPV)-negative head and neck squamous cell carcinomas (HNSCCs) are aggressive cancers with complex genetic underpinnings.
• Previous research implicated genetic mutations in cell signaling, cell cycle, and immune evasion pathways.

Purpose of the Study:

• To investigate the role of epigenome deregulation in the development of HPV-negative HNSCCs.
• To identify novel genetic alterations and their functional consequences in HNSCC oncogenesis.

Main Methods:

• Analysis of public genomic data sets from HNSCC patients.
• Identification and validation of recurrent mutations in H3 histone genes (e.g., K36M alteration).
• Correlation of mutations with DNA methylation patterns and gene expression data.

Main Results:

• Discovery of recurrent p.Lys36Met (K36M) alterations in H3 histone genes in 13% of HPV-negative HNSCCs.
• Identification of a distinct DNA methylation cluster associated with K36M and NSD1 mutations.
• Demonstration that K36M substitution and NSD1 defects impair histone H3 at K36 (H3K36) methylation, hindering cellular differentiation and promoting cancer.

Conclusions:

• Epigenome deregulation, specifically impaired H3K36 methylation, is a key driver in a subset of HPV-negative HNSCCs.
• Novel histone gene mutations and NSD1 defects converge on H3K36 methylation, suggesting therapeutic targets.
• Further research into chromatin regulator-targeting drugs is warranted for these specific HNSCCs.